Plasmapheresis in the treatment of hyperthyroidism associated with agranulocytosis: A case report

Journal of Clinical Apheresis

Volumn 19, Issue 3, 2004, Pages 148-150

  Guvenc, Birol ^a   Unsal, Cagatay ^a   Gurkan, Emel ^a   Dincer, Süleyman ^b  

^a CUKUROVA UNIVERSITY   (Turkey)

^b ANKARA NUMUNE HOSPITAL   (Turkey)

Author keywords

Agranulocytosis; Plasmapheresis; Thyrotoxicosis

Indexed keywords

DIGOXIN; LIOTHYRONINE; PROPRANOLOL; PROPYLTHIOURACIL; THYROTROPIN; THYROXINE;

ADULT; AGRANULOCYTOSIS; ANEMIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DEVICE INFECTION; DYSPNEA; FEMALE; FEVER; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HEART ATRIUM FIBRILLATION; HEART FIBRILLATION; HEART PALPITATION; HUMAN; LEUKOPENIA; PLASMAPHERESIS; SYMPTOM; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; TOXIC GOITER;

AGRANULOCYTOSIS; ANTITHYROID AGENTS; FEMALE; HUMANS; HYPERTHYROIDISM; MIDDLE AGED; PLASMAPHERESIS; PROPYLTHIOURACIL;

EID: 6344237280     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.20014     Document Type: Article

References (26)

1. Cooper DS. Hyperthyroidism. Lancet 2003;362:459-468.
2. Fisher JN. Management of thyrotoxicosis. South Med J 2002;95:493-505.
3. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344:501-509.
4. Ashkar FS, Katims RB, Smoak WM 3rd, Gilson AJ. Thyroid storm treatment with blood exchange and plasmapheresis. JAMA 1970;214:1275-1279.
5. Current status of therapeutic plasmapheresis and related techniques: Report of the AMA Panel on Therapeutic Plasmapheresis, Council of scientific affairs. JAMA FEB 8,1985;253:819-825.
6. Glinoer D. [Treatment of severe exophthalmia using intensive plasma exchange (in French)]. Rev Med Brux 1986;7:379-380,
7. Glinoer D, Etienne-Decerf J, Schrooyen M, Sand G, Hoyoux P, Mahieu P, Winand R. Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy. Acta Endocrinol (Copenh) 1986;111:30-38.
8. Glinoer D. The role of plasmapheresis in Graves' ophthalmopathy. Exp Clin Endocrinol 1991;97:328-331.
9. Bartalena L, Marcocci C, Pinchera A, Treating severe Graves' ophthalmopathy. Baillieres Clin Endocrinol Metab 1997;11:521-536.
10. Geissler D, Ogriseg M, Fill H, Wolf H, [Plasmapheresis treatment in 3 simultaneously occurring autoimmune diseases: Hashimoto thyroiditis with hyperthyroidism, autoimmune thrombopenia and autoimmune hemolytic anemia]. Wien Klin Wochenschr 1987;99:351-355.
11. Braithwaite SS, Brooks MH, Collins S, Bermes EW. Plasmapheresis: an adjunct to medical management of severe hyperthyroidism. J Clin Apheresis 1986;3:119-123.
12. Binimelis J, Bassas L, Marruecos L, Rodriguez J, Domingo ML, Madoz P, Armengol S, Mangues MA, de Leiva A. Massive thyroxine intoxication: evaluation of plasma extraction. Intensive Care Med 1987;13:33-38.
13. Aghini-Lombardi F, Mariotti S, Fosella PV, Grasso L, Pinchera A, Braverman LE, Martino E. Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole. J Endocrinol Invest 1993;16:823-826.
14. Rajeswaran C, Shelton RJ, Gilbey SG. Management of amiodarone-induced thyrotoxicosis. Swiss Med Wkly 2003;133:579-585.
15. Unger J. [Amiodarone and thyroid: pharmacologic and toxic effects]. Rev Med Brux 1996;17:203-205.
16. De Rosa G, Testa A, Menichella G, Cecchini L, Cavallaro A, Mantovani M, Mango G. Plasmapheresis in the therapy of hyperthyroidism associated with leukopenia. Haematologica 1991;76(Suppl 1):72-74.
17. Gabriel EM, Bergert ER, Grant CS, van Heerden JA, Thompson GB, Morris JC. Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter. J Clin Endocrinol Metab 1999;84:3328-3335.
18. Tonacchera M, Agretti P, Chiovato L, Rosellini V, Ceccarini G, Perri A, Viacava P, Naccarato AG, Miccoli P, Pinchera A, Vitti P. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter. J Clin Endocrinol Metab 2000;85:2270-2274.
19. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am 1993;22:263-277.
20. Cobler JL, Williams ME, Greenland P. Thyrotoxicosis in institutionalized elderly patients with atrial fibrillation. Arch Intern Med 1984;144:1758-1760.
21. Trivalle C, Doucet J, Chassagne P, Landrin I, Kadri N, Menard JF, Bercoff E. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc 1996;44:50-53.
22. Shimizu T, Koide S, Noh JY, Sugino K, Ito K, Nakazawa H. Hyperthyroidism and the management of atrial fibrillation. Thyroid 2002;12:489-493.
23. Donatelli M, Assennato P, Abbadi V, Bucalo ML, Compagno V, Lo Vecchio S, Messina L, Russo V, Schembri A, Torregrossa V, Licata G. Cardiac changes in subclinical and overt hyperthyroid women: retrospective study. Int J Cardiol 2003;90:159-164.
24. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D'Agostino RB. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994;331:1249-1252.
25. Sheng WH, Hung CC, Chen YC, Fang CT, Hsieh SM, Chang SC, Hsieh WC. Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections. Qjm 1999;92:455-461.
26. Andres E, Kurtz JE, Perrin AE, Dufour P, Schlienger JL, Maloisel F. Haematopoietic growth factor in antithyroid-drug-induced agranulocytosis. QJ Med 2001;94:423-428.